Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions

(2012) Sneha Narasimhan et al.   PHARMACOGENOMICS

Pharmacological treatment of generalized anxiety disorder

(2011) Jennifer A Reinhold et al.   EXPERT OPINION ON PHARMACOTHERAPY

Time to Relapse After 6 and 12 Months' Treatment of Generalized Anxiety Disorder With Venlafaxine Extended Release

(2010) Karl Rickels et al.   ARCHIVES OF GENERAL PSYCHIATRY

Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region

(2010) Matthew J. Taylor et al.   BIOLOGICAL PSYCHIATRY

Relation of Serotonin Transporter Genetic Variation to Efficacy of Escitalopram for Generalized Anxiety Disorder in Older Adults

(2010) Eric J. Lenze et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

HTR2A gene variation is involved in antidepressant treatment response

(2009) Susanne Lucae et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Refractory Generalized Anxiety Disorder

(2009) Mark H. Pollack   JOURNAL OF CLINICAL PSYCHIATRY

Pharmacogenetics of anxiolytic drugs

(2009) Arun K. Tiwari et al.   JOURNAL OF NEURAL TRANSMISSION

Polymorphisms in GRIK4, HTR2A and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment

(2009) Sonja Horstmann et al.   NEUROPSYCHOPHARMACOLOGY

Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder

(2009) Eugene Lin et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

(2008) M Kato et al.   MOLECULAR PSYCHIATRY

Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response

(2008) Eric J. Peters et al.   Pharmacogenetics and Genomics